Clinical Trials Browser

INDUSTRY × Lymphoma, Mantle-Cell × orelabrutinib × Clear all

NCT06363994 2024-12-27

A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL

Phase 3 Recruiting

Lymphoma, Mantle-Cell

NCT05978739 2023-10-25

Evaluating Different Doses of Orelabrutinib in MCL

Phase 2 Unknown

Lymphoma, Mantle-Cell